Maintien à 3 ans de la réponse clinique sous bimekizumab chez les patients atteints de spondyloarthrite axiale : résultats de deux études de phase III et de leur extension en ouvert.
Saved in:
| Title: | Maintien à 3 ans de la réponse clinique sous bimekizumab chez les patients atteints de spondyloarthrite axiale : résultats de deux études de phase III et de leur extension en ouvert. |
|---|---|
| Authors: | Breban, M.1 (AUTHOR) maxime.breban@ap-hp.fr, Proft, F.2 (AUTHOR), Van Der Heijde, D.3 (AUTHOR), Schwartzman, S.4 (AUTHOR), Taieb, V.5 (AUTHOR), Kavanagh, S.6 (AUTHOR), Varkas, G.7 (AUTHOR), Navarro-Compán, V.8 (AUTHOR), Baraliakos, X.9 (AUTHOR) |
| Source: | Revue du Rhumatisme. 2025 Supplement 1, Vol. 92, pA250-A251. 2p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 189758485 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Maintien à 3 ans de la réponse clinique sous bimekizumab chez les patients atteints de spondyloarthrite axiale : résultats de deux études de phase III et de leur extension en ouvert. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Breban%2C+M%2E%22">Breban, M.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> maxime.breban@ap-hp.fr</i><br /><searchLink fieldCode="AR" term="%22Proft%2C+F%2E%22">Proft, F.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Van+Der+Heijde%2C+D%2E%22">Van Der Heijde, D.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schwartzman%2C+S%2E%22">Schwartzman, S.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Taieb%2C+V%2E%22">Taieb, V.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kavanagh%2C+S%2E%22">Kavanagh, S.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Varkas%2C+G%2E%22">Varkas, G.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Navarro-Compán%2C+V%2E%22">Navarro-Compán, V.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Baraliakos%2C+X%2E%22">Baraliakos, X.</searchLink><relatesTo>9</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Revue+du+Rhumatisme%22">Revue du Rhumatisme</searchLink>. 2025 Supplement 1, Vol. 92, pA250-A251. 2p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=189758485 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.rhum.2025.10.147 Languages: – Code: fre Text: French PhysicalDescription: Pagination: PageCount: 2 StartPage: A250 Titles: – TitleFull: Maintien à 3 ans de la réponse clinique sous bimekizumab chez les patients atteints de spondyloarthrite axiale : résultats de deux études de phase III et de leur extension en ouvert. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Breban, M. – PersonEntity: Name: NameFull: Proft, F. – PersonEntity: Name: NameFull: Van Der Heijde, D. – PersonEntity: Name: NameFull: Schwartzman, S. – PersonEntity: Name: NameFull: Taieb, V. – PersonEntity: Name: NameFull: Kavanagh, S. – PersonEntity: Name: NameFull: Varkas, G. – PersonEntity: Name: NameFull: Navarro-Compán, V. – PersonEntity: Name: NameFull: Baraliakos, X. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 12 Text: 2025 Supplement 1 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 11698330 Numbering: – Type: volume Value: 92 Titles: – TitleFull: Revue du Rhumatisme Type: main |
| ResultId | 1 |
